AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8889399 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Intervention (EI) - SI plus additional educational sessions stressing responsible drug use, including active referral in some cities.
Number of subjects: 2973
Study 8889399 — intervention group
Group type: COMPARATOR
Intervention: Standard Intervention (SI) - HIV testing and counseling.
Number of subjects: 2973
Study 8889399 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment (both SI and EI) compared to other interventions.
Number of subjects: 2973
Study 8889399 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Intervention (EI) with active referral.
Number of subjects: 2973
Study 1686817 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (FLX) treatment
Number of subjects: 10
Study 1686817 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 6624524 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle arthrography combined with a stress inversion test
Number of subjects: 102
Study 6624524 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of peroneus sheath filling
Number of subjects: 102
Study 31092172 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells (MSCs) injection
Number of subjects: 0
Study 31092172 — intervention group
Group type: COMPARATOR
Intervention: Optimized medical therapy (anti-TNF agents) with setons and additional surgical techniques
Number of subjects: 0
Study 29223955 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative HDL cholesterol concentration
Number of subjects: 391
Study 29223955 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term statin use
Number of subjects: 391
Study 29223955 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative atorvastatin treatment
Number of subjects: 391
Study 29223955 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing long-term statin dose
Number of subjects: 391
Study 25339309 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent iodine-125 seed implantation (PSI)
Number of subjects: 312
Study 25339309 — intervention group
Group type: COMPARATOR
Intervention: Combined seeds and external beam radiotherapy (COMB)
Number of subjects: 312
Study 25339309 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival (OS) and disease-specific survival (DSS)
Number of subjects: 312
Study 25339309 — intervention group
Group type: EXPERIMENTAL
Intervention: bRFS
Number of subjects: 312
Study 24321006 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable parental monitoring (84.9%)
Number of subjects: 514
Study 24321006 — intervention group
Group type: EXPERIMENTAL
Intervention: Declining parental monitoring (15.1%)
Number of subjects: 514
Study 22931732 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis (IVT)
Number of subjects: 46
Study 22931732 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 46
Study 19389896 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective termination of pregnancy (TOP) in asymptomatic women
Number of subjects: 143
Study 19389896 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective termination of pregnancy (TOP) in symptomatic women
Number of subjects: 143
Study 19389896 — intervention group
Group type: COMPARATOR
Intervention: Curettage vs no curettage in symptomatic women
Number of subjects: 143
Study 17724088 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin PR (500 mg)
Number of subjects: 18
Study 17724088 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (7.5 mg)
Number of subjects: 18
Study 17724088 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (7.5 mg) + Ciprofloxacin PR (500 mg)
Number of subjects: 18
Study 15339496 — intervention group
Group type: EXPERIMENTAL
Intervention: Kuhuang Injection, Shenmai Injection, Huangqi Liquid (treatment group)
Number of subjects: 101
Study 15339496 — intervention group
Group type: COMPARATOR
Intervention: Ribarvirin and Ganlixin Injection (control group)
Number of subjects: 101
Study 15339496 — intervention group
Group type: EXPERIMENTAL
Intervention: CGIDA (detection method)
Number of subjects: 101
Study 11169084 — intervention group
Group type: EXPERIMENTAL
Intervention: Students viewing 'premature' (PL) infants
Number of subjects: 158
Study 11169084 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-clinical medical students
Number of subjects: 158
Study 11169084 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-level students
Number of subjects: 158
Study 11169084 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-clinical students
Number of subjects: 158
Study 11169084 — intervention group
Group type: COMPARATOR
Intervention: Goal condition (students informed their judgments would be evaluated for accuracy)
Number of subjects: 158
Study 9137798 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate 480 mg/day
Number of subjects: 240
Study 9137798 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate 160 mg/day
Number of subjects: 240
Study 9137798 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 8025391 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow's milk-based formula with 4 mg of iron/l
Number of subjects: 0
Study 8025391 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow's milk-based formula with 7 mg of iron/l
Number of subjects: 0
Study 8025391 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-fed infants
Number of subjects: 0
Study 8025391 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow's milk-based formula with selenium (10 micrograms/l)
Number of subjects: 0
Study 3677508 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic reduction (A) with sliding hip screw
Number of subjects: 18
Study 3677508 — intervention group
Group type: COMPARATOR
Intervention: Medial displacement osteotomy (MD)
Number of subjects: 18
Study 29709498 — intervention group
Group type: EXPERIMENTAL
Intervention: Toe-out gait modification
Number of subjects: 79
Study 29709498 — intervention group
Group type: COMPARATOR
Intervention: Progressive walking
Number of subjects: 79
Study 27871275 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical cerclage
Number of subjects: 170
Study 27871275 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical pessary (Arabin pessary)
Number of subjects: 170
Study 27871275 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (200 mg once daily)
Number of subjects: 170
Study 26517583 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 354
Study 26517583 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 354
Study 26517583 — intervention group
Group type: COMPARATOR
Intervention: Usual activity
Number of subjects: 354
Study 26517583 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid
Number of subjects: 354
Study 26517583 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 354
Study 23594025 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 675
Study 23594025 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 675
Study 23594025 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 675
Study 20499791 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 gr/bid EAAs
Number of subjects: 32
Study 18765330 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise (20 minutes per session, three times per week)
Number of subjects: 112
Study 18765330 — intervention group
Group type: COMPARATOR
Intervention: Non-exercisers
Number of subjects: 112
Study 16615419 — intervention group
Group type: EXPERIMENTAL
Intervention: 201Tl chloride SPECT (TI‐SPECT)
Number of subjects: 41
Study 16615419 — intervention group
Group type: COMPARATOR
Intervention: 99mTc‐MIBI SPECT (MIBI‐SPECT)
Number of subjects: 41
Study 14713325 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic massage (MT)
Number of subjects: 230
Study 14713325 — intervention group
Group type: EXPERIMENTAL
Intervention: Healing touch (HT)
Number of subjects: 230
Study 14713325 — intervention group
Group type: COMPARATOR
Intervention: Presence alone
Number of subjects: 230
Study 14713325 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 230
Study 10999810 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA 50 mg
Number of subjects: 24
Study 10999810 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA 25 mg
Number of subjects: 24
Study 10999810 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 9118514 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg UID
Number of subjects: 206
Study 9118514 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour average BP
Number of subjects: 206
Study 9118514 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-induced changes in average daytime and nighttime BPs
Number of subjects: 206
Study 9118514 — intervention group
Group type: COMPARATOR
Intervention: Clinic BP
Number of subjects: 206
Study 8419392 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of cefotiam, given twelve hours apart
Number of subjects: 239
Study 8419392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study 3025151 — intervention group
Group type: EXPERIMENTAL
Intervention: Various formulations of acyclovir
Number of subjects: 55
Study 30866659 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 104607
Study 28089606 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasacral Transcutaneous Electrical Neural Stimulation (PTENS)
Number of subjects: 16
Study 28089606 — intervention group
Group type: COMPARATOR
Intervention: Urotherapy and electrical stimulation placebo
Number of subjects: 16
Study 28089606 — intervention group
Group type: EXPERIMENTAL
Intervention: PTENS
Number of subjects: 16
Study 25867608 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant therapy (20 mg of esomeprazole, 1 g of amoxicillin, 500 mg of clarithromycin, and 500 mg of metronidazole, twice daily for 10 days)
Number of subjects: 479
Study 25867608 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid therapy (5-day dual therapy of 20 mg of esomeprazole and 1 g of amoxicillin, twice daily followed by 5-day quadruple therapy of 20 mg of esomeprazole, 1 g of amoxicillin, 500 mg of clarithromycin, and 500 mg of metronidazole, twice daily)
Number of subjects: 479
Study 23769010 — intervention group
Group type: EXPERIMENTAL
Intervention: Street children (SG)
Number of subjects: 196
Study 23769010 — intervention group
Group type: COMPARATOR
Intervention: Regular children (CG)
Number of subjects: 196
Study 20854305 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac sodium solution with DMSO
Number of subjects: 24
Study 20854305 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac sodium gel
Number of subjects: 24
Study 19242406 — intervention group
Group type: COMPARATOR
Intervention: 20 mg memantine
Number of subjects: 37
Study 19242406 — intervention group
Group type: COMPARATOR
Intervention: 30 mg memantine
Number of subjects: 37
Study 19242406 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg memantine (in rats)
Number of subjects: 37
Study 19242406 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/kg memantine (in rats)
Number of subjects: 37
Study 17381970 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-fortified noodles
Number of subjects: 425
Study 17381970 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for iron-fortified noodles)
Number of subjects: 425
Study 17381970 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole
Number of subjects: 425
Study 17381970 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for mebendazole)
Number of subjects: 425
Study 14980936 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation with V(T) = 12 or 15 mL/kg ideal body weight, zero end‐expiratory pressure
Number of subjects: 64
Study 14980936 — intervention group
Group type: COMPARATOR
Intervention: Mechanical ventilation with V(T) = 6 mL/kg ideal body weight, positive end‐expiratory pressure of 10 cm H(2)O
Number of subjects: 64
Study 14980936 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ventilatory settings
Number of subjects: 64
Study 11446564 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg daily (n = 59)
Number of subjects: 110
Study 11446564 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 51)
Number of subjects: 110
Study 9543191 — intervention group
Group type: EXPERIMENTAL
Intervention: Root-resective therapy with osseous recontouring and apically positioned flaps
Number of subjects: 72
Study 9543191 — intervention group
Group type: COMPARATOR
Intervention: Surgical procedure identical to test procedure (without root resection)
Number of subjects: 72
Study 8038256 — intervention group
Group type: EXPERIMENTAL
Intervention: Veterans Affairs envelope
Number of subjects: 901
Study 8038256 — intervention group
Group type: COMPARATOR
Intervention: University envelope
Number of subjects: 901
Study 3273486 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 25 micrograms in 5 ml sterile normal saline
Number of subjects: 50
Study 3273486 — intervention group
Group type: COMPARATOR
Intervention: 5 ml of saline
Number of subjects: 50
Study 8494137 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg
Number of subjects: 60
Study 8494137 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg
Number of subjects: 60
Study 8494137 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.25%
Number of subjects: 60
Study 637072 — intervention group
Group type: EXPERIMENTAL
Intervention: Demonstration-training program
Number of subjects: 30
Study 637072 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 30
Study 637072 — intervention group
Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 30
Study 30646422 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg
Number of subjects: 445
Study 30646422 — intervention group
Group type: COMPARATOR
Intervention: No aspirin
Number of subjects: 445
Study 27798546 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids at the start of fluid therapy (group C)
Number of subjects: 128
Study 27798546 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids at step 3 of treatment (group A)
Number of subjects: 128
Study 27798546 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids at step 3 of treatment with adrenal stimulation test (group B)
Number of subjects: 128
Study 27798546 — intervention group
Group type: COMPARATOR
Intervention: Combined group of A and B (group D)
Number of subjects: 128
Study 25709044 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) for antenatal depression and anxiety
Number of subjects: 54
Study 24300755 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 25 mg daily for 6 months
Number of subjects: 66
Study 24300755 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 25 mg daily for 3 months
Number of subjects: 66
Study 24300755 — intervention group
Group type: COMPARATOR
Intervention: Basal therapy with mometasone furoate 400 mcg daily
Number of subjects: 66
Study 21972623 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with infrared irradiation
Number of subjects: 160
Study 21972623 — intervention group
Group type: COMPARATOR
Intervention: Indomethachin (25 mg orally, three times per day for 5 days)
Number of subjects: 160
Study 19959590 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid very low energy diet (2.3 MJ/day) for seven weeks, followed by two weeks of gradual introduction of normal food, reaching 6.3 MJ/day at week 9.
Number of subjects: 63
Study 19959590 — intervention group
Group type: COMPARATOR
Intervention: Usual diet during the nine weeks of follow‐up.
Number of subjects: 63
Study 17095078 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate
Number of subjects: 20
Study 17095078 — intervention group
Group type: COMPARATOR
Intervention: Plasmakinetic enucleation of the prostate
Number of subjects: 20
Study 15491554 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual placental removal (n=200)
Number of subjects: 400
Study 15491554 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous placental separation (n=200)
Number of subjects: 400
Study 11376303 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoprostenol therapy (n = 201)
Number of subjects: 471
Study 11376303 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 235)
Number of subjects: 471
Study 9834590 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamylal 5 mg.kg‐1 with vecuronium 0.1 mg.kg‐1
Number of subjects: 60
Study 9834590 — intervention group
Group type: COMPARATOR
Intervention: Thiamylal 3 mg.kg‐1 with additional thiamylal 4 mg.kg‐1 before intubation and vecuronium 0.1 mg.kg‐1
Number of subjects: 60
Study 9834590 — intervention group
Group type: COMPARATOR
Intervention: Propofol 2.5 mg.kg‐1 with vecuronium 0.1 mg.kg‐1
Number of subjects: 60
Study 7926305 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-hydroxybutyrate (BOHB) infusion
Number of subjects: 0
Study 7926305 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate infusion
Number of subjects: 0
Study 2687006 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxindanac 300 mg b.d.
Number of subjects: 8
Study 2687006 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide 40 mg b.d. with oxindanac
Number of subjects: 8
Study 2687006 — intervention group
Group type: COMPARATOR
Intervention: Frusemide 40 mg b.d. with placebo
Number of subjects: 8
Study 30525943 — intervention group
Group type: EXPERIMENTAL
Intervention: Flax+E1 (Flaxseed + 0.05% enzyme)
Number of subjects: 72
Study 30525943 — intervention group
Group type: EXPERIMENTAL
Intervention: Flax+E2 (Flaxseed + 0.1% enzyme)
Number of subjects: 72
Study 30525943 — intervention group
Group type: EXPERIMENTAL
Intervention: Flax (10% flax)
Number of subjects: 72
Study 30525943 — intervention group
Group type: COMPARATOR
Intervention: Control (0% flax)
Number of subjects: 72
Study 28902073 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 220
Study 28902073 — intervention group
Group type: COMPARATOR
Intervention: No treatment (standard of care)
Number of subjects: 220
Study 28902073 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy (among hrHPV+ women)
Number of subjects: 220
Study 28902073 — intervention group
Group type: COMPARATOR
Intervention: No treatment (among hrHPV+ women)
Number of subjects: 220
Study 26168736 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin treatment
Number of subjects: 72
Study 23483214 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body progressive resistance training (PRT) for 12 weeks
Number of subjects: 38
Study 23483214 — intervention group
Group type: COMPARATOR
Intervention: Control group maintaining usual daily activity
Number of subjects: 38
Study 21600129 — intervention group
Group type: EXPERIMENTAL
Intervention: Target Controlled Infusion (TCI) of propofol at an initial plasma concentration of 2.0 µg/ml, titrated upwards by 0.5 µg/ml steps until loss of consciousness
Number of subjects: 60
Study 21600129 — intervention group
Group type: COMPARATOR
Intervention: Manual Controlled Infusion (MCI) of propofol at 200 ml/h
Number of subjects: 60
Study 21600129 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups received an infusion of remifentanil
Number of subjects: 60
Study 21600129 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 18304848 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage programme with relaxation techniques
Number of subjects: 0
Study 18304848 — intervention group
Group type: COMPARATOR
Intervention: Music with relaxation techniques (placebo)
Number of subjects: 0
Study 18304848 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study 16420540 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol cream
Number of subjects: 2
Study 16420540 — intervention group
Group type: EXPERIMENTAL
Intervention: Canola oil cream
Number of subjects: 2
Study 16420540 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisabolol cream
Number of subjects: 2
Study 16420540 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbomer cream
Number of subjects: 2
Study 16420540 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic cream
Number of subjects: 2
Study 16420540 — intervention group
Group type: EXPERIMENTAL
Intervention: IPP cream
Number of subjects: 2
Study 12904840 — intervention group
Group type: COMPARATOR
Intervention: Calcium (1 g) and vitamin D (800 units of cholecalciferol) only (group 1: n=35)
Number of subjects: 71
Study 12904840 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium/vitamin D and nutritional supplement drink providing 300 Kcal, 12 g protein, 11.6 g fat, and 36.8 g carbohydrate per carton (group 2: n=36)
Number of subjects: 71
Study 12904840 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium/vitamin D and nutritional supplement drink (group 2)
Number of subjects: 71
Study 11309029 — intervention group
Group type: EXPERIMENTAL
Intervention: Bexarotene capsules (300 mg/m2 per day)
Number of subjects: 8
Study 11309029 — intervention group
Group type: EXPERIMENTAL
Intervention: Bexarotene gel
Number of subjects: 8
Study 9926060 — intervention group
Group type: EXPERIMENTAL
Intervention: Community mental health services
Number of subjects: 0
Study 9926060 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive sector community services
Number of subjects: 0
Study 9926060 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-team model for acute and continuing care
Number of subjects: 0
Study 9926060 — intervention group
Group type: COMPARATOR
Intervention: General community mental health model
Number of subjects: 0
Study 8041536 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative modified biophysical profile
Number of subjects: 5444
Study 8041536 — intervention group
Group type: COMPARATOR
Intervention: Negative contraction stress test (CST)
Number of subjects: 5444
Study 2925967 — intervention group
Group type: EXPERIMENTAL
Intervention: Running
Number of subjects: 40
Study 2925967 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Lifting
Number of subjects: 40
Study 2925967 — intervention group
Group type: COMPARATOR
Intervention: Delayed Treatment (Control)
Number of subjects: 40
Study 4103276 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mug of anti-D gammaglobulin given intramuscularly
Number of subjects: 349
Study 4103276 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 349